Revestive (teduglutide)

pCPA File Number: 20950
Negotiation Status:
Concluded with an LOI
Indication(s):
Short Bowel Syndrome (SBS)
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CADTH Project Number:
SR0459-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: